retatrutide type 2 diabetes phase 2 trial weight loss 2024 Retatrutide, an experimental weight-loss drug Retatrutide Helped Adults With Diabetes

While this approach allowed us to include all available subjects, it limits interpretation of potential sex-specific effects

The maximum approved dose is 15 mg once weekly, typically reached by week 20 or 21 of treatment

Support resources should be utilized as needed

A substudy examining participants with metabolic-associated steatotic liver disease produced results that no pharmacological intervention had previously achieved

Regular check-ins with your prescribing provider should include honest conversations about your weight trends, quality of life on medication, and sustainability of your regimen

Avoid injecting into or immediately adjacent to scars